Your town. Your news. Your take.

Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

 
Advertisment

Bayer Schering Pharma AG Wire

Comprehensive News Feed for Bayer Schering Pharma AG.

Results 1 - 20 of 54 in Bayer Schering Pharma AG

  1. World Contraception Day --Read the original story

    Saturday Sep 20 | Trinidad & Tobago Express

    ... and the International Federation of Pediatric and Adolescent Gynaecology. It is supported by Bayer Schering Pharma AG, which has a long history in women's health. What is this year's campaign focusing on? According to Nadia Ramsarran, a member of ...

    Comment?

    Related Topix: Women's Health, Health

  2. New Low-Dose Oral Contraceptive Yaz Launched in EuropeRead the original story

    Sep 8, 2008 | Drugs.com

    ... often occur with conventional 21/7 pills," said Phil Smits, M.D., Head of Women's Healthcare at Bayer Schering Pharma AG. "Women who usually experience hormone withdrawal symptoms such as headaches or cramps during the pill-free week should benefit ...

    Comment?

    Related Topix: Manufacturing, Biotech, Bayer AG, Chemicals

  3. Over 900 MEDRAD(R) Employees Volunteer Time, Resources TodayRead the original story

    Friday Sep 12 | PR Newswire

    ... Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma AG. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more ...

    Comment?

    Related Topix: Pittsburgh Metro, Medicine, Medical Equipment, Healthcare Industry, Manufacturing, Bayer AG, Biotech, Chemicals

  4. Over 900 MEDRAD(R) Employees Volunteer Time, Resources TodayRead the original story

    Friday Sep 12 | PR Newswire

    ... Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma AG. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more ...

    Comment?

    Related Topix: Pittsburgh Metro, Medicine, Medical Equipment, Healthcare Industry, Manufacturing, Bayer AG, Biotech, Chemicals

  5. New Low Dose Oral Contraceptive YAZ Launched In EuropeRead the original story

    Sep 9, 2008 | Medical News Today

    ... often occur with conventional 21/7 pills," said Phil Smits, M.D., Head of Women's Healthcare at Bayer Schering Pharma AG. "Women who usually experience hormone withdrawal symptoms such as headaches or cramps during the pill-free week should benefit ...

    Comment?

    Related Topix: Pharmaceuticals, Manufacturing, Biotech, Bayer AG, Chemicals

  6. New Low Dose Oral Contraceptive YAZ Launched In EuropeRead the original story

    Sep 9, 2008 | MediLexicon

    ... often occur with conventional 21/7 pills," said Phil Smits, M.D., Head of Women's Healthcare at Bayer Schering Pharma AG. "Women who usually experience hormone withdrawal symptoms such as headaches or cramps during the pill-free week should benefit ...

    Comment?

    Related Topix: Pharmaceuticals, Manufacturing, Biotech, Bayer AG, Chemicals

  7. New low-dose oral contraceptive YAZ launched in EuropeRead the original story

    Sep 8, 2008 | WebWire

    ... often occur with conventional 21/7 pills," said Phil Smits, M.D., Head of Women's Healthcare at Bayer Schering Pharma AG. "Women who usually experience hormone withdrawal symptoms such as headaches or cramps during the pill-free week should benefit ...

    Comment?

  8. Epix buys back distribution rights from Bayer: Vasovist is the only...

    Sep 7, 2008 | Customer Interaction Solutions

    ... for its imaging product, blood pool magnetic resonance angiography (MRA) agent, Vasovist, from Bayer Schering Pharma AG. The agreement will expire in March 2009. Vasovist is the only Epix product with sales, and Bayer markets it in 19 countries. ...

    Comment?

    Related Topix: Pharmaceuticals, Marketing, Food and Drug Administration

  9. Indevus Receives Approvable Letter from FDA for NebidoRead the original story

    Jun 30, 2008 | Drugs.com

    ... provides a road map for the product's eventual approval. We will work with the FDA and our partner, Bayer Schering Pharma AG, to respond to the approvable letter and devise a plan to address the deficiencies. While the FDA has not specifically ...

    Comment?

    Related Topix: Marketing, Biotech, Medicine, Indevus Pharmaceuticals, Healthcare Industry, Food and Drug Administration

  10. Confirma and MEDRAD Partner to Advance Patient Care in the European UnionRead the original story

    Aug 27, 2008 | Business Wire

    ... , Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma AG. Bayer HealthCare '

    Comment?

    Related Topix: University of Washington, Medicine, Medical Equipment, Healthcare Industry, Health, Prostate Cancer

  11. Bayer Schering Pharma To Support USAID With Contraceptives For Family Planning Programs

    Aug 26, 2008 | MediLexicon

    Bayer Schering Pharma AG, Germany, will supply up to 110 million cycles of oral contraceptives yearly for family planning programs supported by the U.S. Agency for International Development in developing ...

    Comment?

    Related Topix: Marketing, Pharmaceuticals, Manufacturing, Biotech, Bayer AG, Chemicals, Health

  12. MEDRAD Receives FDA 510(k) Clearance For Wireless MR Infusion SystemRead the original story

    Aug 12, 2008 | Medical News Today

    ... Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma AG. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more ...

    Comment?

    Related Topix: Food and Drug Administration, Medicine, Medical Equipment, Healthcare Industry

  13. MEDRAD Receives FDA 510(k) Clearance For Wireless MR Infusion SystemRead the original story

    Aug 12, 2008 | MediLexicon

    ... Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma AG. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more ...

    Comment?

    Related Topix: Food and Drug Administration, Medicine, Medical Equipment, Healthcare Industry

  14. MEDRAD Receives FDA 510(k) Clearance for Wireless MR Infusion SystemRead the original story

    Aug 11, 2008 | PR Newswire

    ... Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma AG. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more ...

    Comment?

    Related Topix: Food and Drug Administration, Medicine, Medical Equipment, Healthcare Industry

  15. Packing Power Into ProductsRead the original story

    Aug 10, 2008 | Philly.com

    ... is rebellious freedom," Glatcz said. In the same way, he said, Angeliq, a menopause drug sold by Bayer Schering Pharma AG, signifies femininity and beauty. (Never mind that sound-alike celebrity Angelina Jolie is decidedly not menopausal.) The right ...

    Comment?

    Related Topix: Saint Joseph's University

  16. Bayer Schering Pharma Buys Nycomed Pharma's Preclinical Oncology ProgramRead the original story

    Aug 8, 2008 | BioSpace

    Bayer Schering Pharma AG said it is acquiring a preclinical anti-cancer programme from Nycomed as part of its expansion of its oncology pipeline.

    Comment?

    Related Topix: Pharmaceuticals, Oncology, Medicine

  17. MEDRAD Installs First Intego(TM) PET Infusion SystemRead the original story

    Jul 8, 2008 | PR Newswire

    ... Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma AG. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more ...

    Comment?

    Related Topix: University of Pittsburgh, Pittsburgh Metro, Medicine, Medical Equipment, Healthcare Industry

  18. Bayer Acquires Preclinical Anti-Cancer Program From Nycomed

    Aug 7, 2008 | Med Ad News

    Bayer Schering Pharma AG, Germany, is expanding its oncology pipeline with the acquisition of a preclinical oncology program from Nycomed, a pharmaceutical company headquartered in Switzerland.

    Comment?

    Related Topix: Pharmaceuticals, Medicine, Oncology, Manufacturing, Biotech, Bayer AG, Chemicals

  19. Indevus Pharmaceuticals Announces Third Quarter Fiscal 2008 Financial ResultsRead the original story

    May 8, 2008 | PR Newswire

    ... labeling, as it is in Europe. The Company is continuing to work with the FDA and our partner, Bayer Schering Pharma AG, to address the issues summarized in the letter. We anticipate being able to discuss our future plans with NEBIDO in the coming ...

    Comment?

    Related Topix: Lexington, MA, Biotech, Medicine, Indevus Pharmaceuticals, Healthcare Industry, Supprelin, Histrelin (generic), Medication

  20. Primovist(R) Approved In The U.S. For The Detection And Characterization Of Liver LesionsRead the original story

    Jul 9, 2008 | Medical News Today

    ... tiny pathological liver lesions," said Dr. Gunnar Riemann, Member of the Board of Management of Bayer Schering Pharma AG, responsible for the company's Business Units. "Bayer is now in the unique position of offering Primovist for diagnosing ...

    Comment?

    Related Topix: Hepatitis, Health, Food and Drug Administration, Manufacturing, Biotech, Bayer AG, Chemicals